Airway reflux, cough and respiratory disease

Therapeutic Advances in Chronic Disease

Volumn 2, Issue 4, 2011, Pages 237-248

  Molyneux, Ian D ^a   Morice, Alyn H ^a  

^a UNIVERSITY OF HULL   (United Kingdom)

Author keywords

airways reflux; cough; respiratory disease; therapy

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; 4 AMINOBUTYRIC ACID RECEPTOR STIMULATING AGENT; ANTIHISTAMINIC AGENT; ATROPINE; AZITHROMYCIN; BACLOFEN; CISAPRIDE; DOMPERIDONE; ERYTHROMYCIN; ESOMEPRAZOLE; LESOGABERAN; METABOTROPIC RECEPTOR ANTAGONIST; METOCLOPRAMIDE; OMEPRAZOLE; PLACEBO; PROTON PUMP INHIBITOR;

AIRWAY REFLUX; ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; COUGHING; CYSTIC FIBROSIS; DISEASE ASSOCIATION; DRUG MEGADOSE; GASTROESOPHAGEAL REFLUX; HUMAN; INTERSTITIAL LUNG DISEASE; LARYNGOPHARYNGEAL REFLUX; LOW DRUG DOSE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; REVIEW; SLEEP APNEA SYNDROME; SYMPTOMATOLOGY;

EID: 79960074642     PISSN: 20406223     EISSN: 20406231     Source Type: Journal    
DOI: 10.1177/2040622311406464     Document Type: Review

References (108)

1. Aanen M.C. Weusten B.L. Numans M.E. de Wit N.J. Baron A. Smout A.J. (2006) Diagnostic value of the proton pump inhibitor test for gastro-oesophageal reflux disease in primary care. Aliment Pharmacol Ther 24: 1377–1384.
2. Allen C.J. Anvari M. (1998) Gastro-oesophageal reflux related cough and its response to laparoscopic fundoplication. Thorax 53: 963–968.
3. Axford S.E. Sharp N. Ross P.E. Pearson J.P. Dettmar P.W. Panetti M. et al (2001) Cell biology of laryngeal epithelial defenses in health and disease: Preliminary studies. Ann Otol Rhinol Laryngol 110: 1099–1108.
4. Ayazi S. Lipham J.C. Hagen J.A. Tang A.L. Zehetner J. Leers J.M. et al (2009) A new technique for measurement of pharyngeal pH: Normal values and discriminating pH threshold. J Gastrointest Surg 13: 1422–1429.
5. Balaji N.S. Blom D. de Meester T.R. Peters J.H. (2003) Redefining gastroesophageal reflux (GER). Surg Endosc 17: 1380–1385.
6. Barnes P.J. (2001) Neurogenic inflammation in the airways. Respir Physiol 125: 145–154.
7. Belafsky P.C. Postma G.N. Koufman J.A. (2001) The validity and reliability of the reflux finding score (RFS). Laryngoscope 111: 1313–1317.
8. Belafsky P.C. Rees C.J. Rodriguez K. Pryor J.S. Katz P.O. (2008) Esophagopharyngeal reflux. Otolaryngol Head Neck Surg 138: 57–61.
9. Berquist W.E. Rachelefsky G.S. Kadden M. Siegel S.C. Katz R.M. Mickey M.R. et al (1981) Effect of theophylline on gastroesophageal reflux in normal adults. J Allergy Clin Immunol 67: 407–411.
10. Bevan S. Geppetti P. (1994) Protons: Small stimulants of capsaicin-sensitive sensory nerves. Trends Neurosci 17: 509–512.
11. Blackshaw L.A. (2008) New insights in the neural regulation of the lower oesophageal sphincter. Eur Rev Med Pharmacol Sci 12(Suppl 1): 33–39.
12. Blondeau K. Dupont L.J. Mertens V. Verleden G. Malfroot A. Vandenplas Y. et al (2008 a) Gastro-oesophageal reflux and aspiration of gastric contents in adult patients with cystic fibrosis. Gut 57: 1049–1055.
13. Blondeau K. Mertens V. Vanaudenaerde B.A. Verleden G.M. van Raemdonck D.E. Sifrim D. (2008 b) Gastro-oesophageal reflux and gastric aspiration in lung transplant patients with or without chronic rejection. Eur Respir J 31: 707–713.
14. Boeckxstaens G.E. Beaumont H. Mertens V. Denison H. Ruth M. Adler J. et al (2010) Effects of lesogaberan on reflux and lower esophageal sphincter function in patients with gastroesophageal reflux disease. Gastroenterology 139: 409–417.
15. Boekema P.J. Samsom M. van Berge Henegouwen G.P. Smout A.J. (1999) Coffee and gastrointestinal function: Facts and fiction. A review. Scand J Gastroenterol Suppl 230: 35–39.
16. Bredenoord A.J. (2009) Lesogaberan, a GABA(B) agonist for the potential treatment of gastroesophageal reflux disease. IDrugs 12: 576–584.
17. Broeders J.A. Draaisma W.A. Bredenoord A.J. Smout A.J. Broeders A. Gooszen H.G. (2010) Long-term outcome of Nissen fundoplication in non-erosive and erosive gastro-oesophageal reflux disease. Br J Surg 97: 845–852.
18. Casanova C. Baudet J.S. del Valle Velasco M. Martin J.M. Aguirre-Jaime A. de Torres J.P. et al (2004) Increased gastro-oesophageal reflux disease in patients with severe COPD. Eur Respir J 23: 841–845.
19. Chang A.B. Lasserson T.J. Gaffney J. Connor F.L. Garske L.A. (2006) Gastro-oesophageal reflux treatment for prolonged non-specific cough in children and adults. Cochrane Database Syst Rev 18: CD004823–CD004823.
20. Cool M. Poelsmans J. Feenstra L. Tack J. (2004) Characteristics and clinical relevance of proximal esophageal pH monitoring. Am J Gastroenterol 99: 2317–2323.
21. Deane A.M. Fraser R.J. Chapman M.J. (2009) Prokinetic drugs for feed intolerance in critical illness: Current and potential therapies. Crit Care Resusc 11: 132–143.
22. Dent J. Dodds W.J. Friedman R.H. Sekiguchi T. Hogan W.J. Arndorfer R.C. et al (1980) Mechanism of gastroesophageal reflux in recumbent asymptomatic human subjects. J Clin Invest 65: 256–267.
23. Dicpinigaitis P.V. (2006) Chronic cough due to asthma: ACCP evidence-based clinical practice guidelines. Chest 129(1 Suppl): 75S–79S.
24. Doherty M.J. Mister R. Pearson M.G. Calverley P.M. (2000 a) Capsaicin responsiveness and cough in asthma and chronic obstructive pulmonary disease. Thorax 55: 643–649.
25. Doherty M.J. Mister R. Pearson M.G. Calverley P.M. (2000 b) Capsaicin induced cough in cryptogenic fibrosing alveolitis. Thorax 55: 1028–1032.
26. D'Ovidio F. Mura M. Ridsdale R. Takahashi H. Waddell T.K. Hutcheon M. et al (2006) The effect of reflux and bile acid aspiration on the lung allograft and its surfactant and innate immunity molecules SP-A and SP-D. Am J Transplant 6: 1930–1938.
27. El-Serag H.B. Sonnenberg A. (1997) Comorbid occurrence of laryngeal or pulmonary disease with esophagitis in United States military veterans. Gastroenterology 113: 755–760.
28. Eryuksel E. Dogan M. Olgun S. (2009) Incidence and treatment results of laryngopharyngeal reflux in chronic obstructive pulmonary disease. Eur Arch Otorhinolaryngol 266: 1267–1271.
29. Everett C.F. Morice A.H. (2007) Clinical history in gastroesophageal cough. Respir Med 101: 345–348.
30. Fang J.C. Sarosiek I. Yamamoto Y. (1999) Cholinergic blockade inhibits gastro-oesophageal reflux and transient lower oesophageal sphincter relaxation through a central mechanism. Gut 44: 603–637.
31. Farré R. Fornari F. Blondeau K. Vieth M. de Vos R. Bisschops R. et al (2010) Acid and weakly acidic solutions impair mucosal integrity of distal exposed and proximal non-exposed human oesophagus. Gut 59: 164–169.
32. Farrell T.M. Richardson W.S. Trus T.L. Smith C.D. Hunter J.G. (2001) Response of atypical symptoms of gastro-oesophageal reflux to antireflux surgery. Br J Surg 88: 1649–1652.
33. Fathi H. Moon T. Donaldson J. Jackson W. Sedman P. Morice A.H. (2009) Cough in adult cystic fibrosis: Diagnosis and response to fundoplication. Cough 5: 1–2.
34. Ferrari M. Benini L. Brotto E. Locatelli F. de Ioiro F. Bonella F. et al (2007) Omeprazole reduces the response to capsaicin but not to methacholine in asthmatic patients with proximal reflux. Scand J Gastroenterol 42: 299–307.
35. Ford A.C. Forman D. Mosyyedi P. Morice A.H. (2006) Cough in the community: A cross sectional survey and the relationship to gastrointestinal symptoms. Thorax 61: 975–979.
36. Grossi L. Ciccaglione A.F. Marzio L. (2001) Transient lower oesophageal sphincter relaxations play an insignificant role in gastro-oesophageal reflux to the proximal oesophagus. Neurogastroenterol Motil 13: 503–509.
37. Gunnbjörnsdóttir M.I. Omenaas E. Gíslason T. Norrman E. Olin A.C. Jõgi R. et al (2004) Obesity and nocturnal gastro-oesophageal reflux are related to onset of asthma and respiratory symptoms. Eur Respir J 24: 116–121.
38. Helm J.F. (1986) Esophageal acid clearance. J Clin Gastroenterol 8(Suppl 1): 5–11.
39. Holloway R.H. (2001) Systemic pharmacomodulation of transient lower esophageal sphincter relaxations. Am J Med 111(Suppl 8A): 178S–185S.
40. Ikramuddin S. (2008) Surgical management of gastroesophageal reflux disease in obesity. Dig Dis Sci 53: 2318–2329.
41. Irwin R.S. Curley F.J. French C.L. (1990) Chronic cough. The spectrum and frequency of causes, key components of the diagnostic evaluation and outcome of specific therapy. Am Rev Respir Dis 141: 640–647.
42. Jack C.I. Calverley P.M. Donnelly R.J. Tran J. Russell G. Hind C.R. (1995) Simultaneous tracheal and oesophageal pH measurements in asthmatic patients with gastro-oesophageal reflux. Thorax 50: 201–204.
43. Jacobson B.C. Somers S.C. Fuchs C.S. Kelly C.P. Camargo C.A. (2006) Body-mass index and symptoms of gastroesophageal reflux in women. N Engl J Med 354: 2340–2348.
44. Jaspersen D. Kulig M. Labenz J. Leodolter A. Lind T. Meyer-Sabelleck K. et al (2003) Prevalence of extra-oesophageal manifestations in gastro-oesophageal reflux disease: An analysis based on the ProGERD Study. Aliment Pharmacol Ther 17: 1515–1520.
45. Jaspersen D. Labenz J. Willich S.N. Kulig M. Nocon M. Leodolter A. et al (2006) Long-term clinical course of extra-oesophageal manifestations in patients with gastro-oesophageal reflux disease: A prospective follow-up analysis based on the ProGERD study. Dig Liver Dis 38: 233–238.
46. Jensen J. Lehmann A. Uvebrant A. Carlsson A. Jerndal G. Nilsson K. et al (2005) Transient lower esophageal sphincter relaxations in dogs are inhibited by a metabotropic glutamate receptor 5 antagonist. Eur J Pharmacol 519: 154–157.
47. Johnston N. Bulmer D. Gill G.A. Panetti M. Ross P.E. Pearson J.P. et al (2003) Cell biology of laryngeal epithelial defences in health and disease: Further studies. Ann Otol Rhinol Laryngol 112: 481–491.
48. Johnston N. Wells C.W. Samuels T.L. Blumin J.H. (2009) Pepsin in nonacidic refluxate can damage hypopharyngeal epithelial cells. Ann Otol Rhinol Laryngol 118: 677–685.
49. Jonaitis L. Pribuisiene R. Kupcinskas L. Uloza V. (2006) Laryngeal examination is superior to endoscopy in the diagnosis of the laryngopharyngeal form of gastroesophageal reflux disease. Scand J Gastroenterol 41: 131–137.
50. Jordt S.E. Bautista D.M. Chuang H.H. McKemy D.D. Zygmunt P.M. Högestätt E.D. et al (2004) Mustard oils and cannabinoids excite sensory nerve fibres through the TRP channel ANKTM1. Nature 427: 260–265.
51. Karkos P.D. Benton J. Leong S.C. Karkanevatos A. Badran K. Srinivasan V.R. et al (2007) Trends in laryngopharyngeal reflux: A British ENT survey. Eur Arch Otorhinolaryngol 264: 513–517.
52. Kastelik J.A. Redington A.E. Aziz I. Buckton G.K. Smith C.M. Dakkak M. et al (2003) Abnormal oesophageal motility in patients with chronic cough. Thorax 58: 699–702.
53. Kawamura O. Aslam M. Rittmann T. Hofmann C. Shaker R. (2004) Physical and pH properties of gastroesophagopharyngeal refluxate: A 24-hour simultaneous ambulatory impedance and pH monitoring study. Am J Gastroenterol 99: 1000–1010.
54. Kempainen R.R. Savik K. Whelan T.P. Dunitz J.M. Herrington C.S. Billings J.L. (2007) High prevalence of proximal and distal gastroesophageal reflux disease in advanced COPD. Chest 131: 1666–1671.
55. Kiljander T.O. Laitinen J.O. (2004) The prevalence of gastroesophageal reflux disease in adult asthmatics. Chest 126: 1490–1494.
56. Knight J. Lively M.O. Johnston N. Dettmar P.W. Koufman J.A. (2005) Sensitive pepsin immunoassay for detection of laryngopharyngeal reflux. Laryngoscope 115: 1473–1478.
57. Koufman J.A. Aviv J.E. Casiano R.R. Shaw G.Y. (2002) Laryngopharyngeal reflux: Position statement of the committee on speech, voice, and swallowing disorders of the American Academy of Otolaryngology-Head and Neck Surgery. Otolaryngol Head Neck Surg 127: 32–35.
58. Kuribayashi S. Massey B.T. Hafeezullah M. Perera L. Hussaini S.Q. Tatro L. et al (2010) Upper esophageal sphincter and gastroesophageal junction pressure changes act to prevent gastroesophageal and esophagopharyngeal reflux during apneic episodes in patients with obstructive sleep apnea. Chest 137: 769–776.
59. Lacy B.E. Mathis C. DesBiens J. Liu M.C. (2008) The effects of nebulized albuterol on esophageal function in asthmatic patients. Dig Dis Sci 53: 2627–2633.
60. Laitman J.T. Reidenberg J.S. (1997) The human aerodigestive tract and gastroesophageal reflux: An evolutionary perspective. Am J Med 103: 2S–8S.
61. Ledson M. Tran J.J. Walshaw M.J. (1998) Prevalence and mechanisms of gastro-oesophageal reflux in adult cystic fibrosis patients. J R Soc Med 91: 7–9.
62. Lee J.S. Collard H.R. Raghu G. Sweet M.P. Hays S.R. Campos G.M. et al (2010) Does chronic microaspiration cause idiopathic pulmonary fibrosis? Am J Med 123: 304–311.
63. Mainie I. Tutuian R. Shay S. Vela M. Zhang X. Sifrim D. et al (2006) Acid and non-acid reflux in patients with persistent symptoms despite acid suppressive therapy: A multicentre study using combined ambulatory impedance-pH monitoring. Gut 55: 1398–1402.
64. Mastronarde J.G. Anthonisen N.R. Castro M. Holbrook J.T. Leone F.T. Teague W.G. et al (2009) Efficacy of esomeprazole for treatment of poorly controlled asthma. N Engl J Med 360: 1487–1499.
65. Matthews P.J. Aziz Q. Facer P. Davis J.B. Thompson D.G. Anand P. (2004) Increased capsaicin receptor TRPV 1 nerve fibres in the inflamed human oesophagus. Eur J Gastroenterol Hepatol 16: 897–902.
66. Mays E.E. (1976) Intrinsic asthma in adults. Association with gastroesophageal reflux. JAMA 236: 2626–2628.
67. Mays E.E. Dubois J.J. Hamilton G.B. (1976) Pulmonary fibrosis associated with tracheobronchial aspiration. A study of the frequency of hiatal hernia and gastroesophageal reflux in interstitial pulmonary fibrosis of obscure etiology. Chest 69: 512–515.
68. Merati A.L. Lim H.J. Ulualp S.O. Toohill R.J. (2005) Meta-analysis of upper probe measurements in normal subjects and patients with laryngopharyngeal reflux. Ann Otol Rhinol Laryngol 114: 177–182.
69. Mertens V. Blondeau K. Pauwels A. Farre R. Vanaudenaerde B. Vos R. et al (2009) Azithromycin reduces gastroesophageal reflux and aspiration in lung transplant recipients. Dig Dis Sci 54: 972–979.
70. Midgren B. Hansson L. Karlsson J.A. Simonsson B.G. Persson C.G. (1992) Capsaicin-induced cough in humans. Am Rev Respir Dis 146: 347–351.
71. Mitchell J.E. Campbell A.P. New N.E. Sadofsky L.R. Kastelik J.A. Mulrennan S.A. et al (2005) Expression and characterization of the intracellular vanilloid receptor (TRPV1) in bronchi from patients with chronic cough. Exp Lung Res 31: 295–306.
72. Mittal R.K. Holloway R.H. Penagini R. Blackshaw L.A. Dent J. (1995) Transient lower esophageal sphincter relaxation. Gastroenterology 109: 601–610.
73. Molyneux I. Jackson W. Morice A.H. (2010 a) Variation in pharyngeal pH in the diagnosis of respiratory reflux. Thorax 65(Suppl IV): A55–A55. abstract.
74. Molyneux I. Morice A.H. Jackson W. (2010 b) Enhanced detection of airway reflux using pharyngeal pH monitoring. Am J Respir Crit Care Med 181: A5903–A5903. abstract.
75. Morice A.H. Faruqi S. Wright C.E. Thompson R. Bland J.M. (2011) The cough hypersensitivity syndrome: A distinct clinical entity. Lung 189: 73–79.
76. Morice A.H. Fontana G.A. Belvisi M.G. Birring S.S. Chung K.F. Dicpinigaitis P.V. et al (2007) ERS guidelines on the assessment of cough. Eur Respir J 29: 1256–1276.
77. Nordenstedt H. Nilsson M. Johansson S. Wallander M.A. Johnsen R. Hveem K. et al (2006) The relation between gastro-oesophageal reflux and respiratory symptoms in a population-based study: the North-Trøndelag health survey. Chest 129: 1051–1056.
78. O'Connell F. Thomas V.E. Studham J.M. Pride N.B. Fuller R.W. (1996) Capsaicin cough sensitivity increases during upper respiratory infection. Respir Med 90: 279–286.
79. Oelschlager B.K. Chang L. Pope C.E. 2nd Pellegrini C.A. (2005) Typical GERD symptoms and esophageal pH monitoring are not enough to diagnose pharyngeal reflux. J Surg Res 128: 55–60.
80. Oh D.S. Hagen J.A. Fein M. Bremner C.G. Dunst C.M. de Meester S.R. et al (2006) The impact of reflux composition on mucosal injury and esophageal function. J Gastrointest Surg 10: 787–797.
81. Pandolfino J.E. Ghosh S.K. Zhang Q. Han A. Kahrilas P.J. (2007) Upper sphincter function during transient lower oesophageal sphincter relaxation (tLOSR); It is mainly about microburps. Neurogastroenterol Motil 19: 203–210.
82. Pandolfino J.E. Kahrilas P.J. (2000) Smoking and gastro-oesophageal reflux disease. Eur J Gastroenterol Hepatol 12: 837–842.
83. Patterson N. Mainie I. Rafferty G. McGarvey L. Heaney L. Tutuian R. et al (2009) Nonacid reflux episodes reaching the pharynx are important factors associated with cough. J Clin Gastroenterol 43: 414–419.
84. Patterson R.N. Johnston B.T. Ardill J.E. Heaney L.G. McGarvey L.P. (2007) Increased tachykinin levels in induced sputum from asthmatic and cough patients with acid reflux. Thorax 62: 491–495.
85. Pauwels A. Blondeau K. Dupont L. Sifrim D. (2009) Cough and gastroesophageal reflux: From the gastroenterologist end. Pulm Pharmacol Ther 22: 135–138.
86. Phua S.Y. McGarvey L.P. Ngu M.C. Ing A.J. (2005) Patients with gastro-oesophageal reflux disease and cough have impaired laryngopharyngeal mechanosensitivity. Thorax 60: 488–491.
87. Poe R.H. Kallay M.C. (2003) Chronic cough and gastroesophageal reflux disease: Experience with specific therapy for diagnosis and treatment. Chest 123: 679–684.
88. Pontes P. Tiago R. (2006) Diagnosis and management of laryngopharyngeal reflux disease. Curr Opin Otolaryngol Head Neck Surg 14: 138–142.
89. Postma G.N. Tomek M.S. Belafsky P.C. Koufman J.A. (2001) Esophageal motor function in laryngopharyngeal reflux is superior to that in classic gastroesophageal reflux disease. Ann Otol Rhinol Laryngol 110: 1114–1116.
90. Pratter M.R. Brightling C.E. Boulet L.P. Irwin R.S. (2006) An empiric integrative approach to the management of cough: ACCP evidence-based clinical practice guidelines. Chest 129: 222S–231S.
91. Ruhl C.E. Sonnenberg A. Everhart J.E. (2001) Hospitalization with respiratory disease following hiatal hernia and reflux esophagitis in a prospective, population-based study. Ann Epidemiol 11: 477–483.
92. Sabati A.A. Kempainen R.R. Milla C.E. Ireland M. Schwarzenberg S.J. Dunitz J.M. et al (2010) Characteristics of gastroesophageal reflux in adults with cystic fibrosis. J Cyst Fibros 9 (5): 365–370. doi:10.1016/j.jcf.2010.06.004.
93. Salvioli B. Belmonte G. Stanghellini V. Baldi E. Fasano L. Pacilli A.M. et al (2006) Gastro-oesophageal reflux and interstitial lung disease. Dig Liver Dis 38: 879–884.
94. Scheffer R.C. Akkermans L.M. Bais J.E. Roelofs J.M. Smout A.J. Gooszen H.G. (2002) Elicitation of transient lower oesophageal sphincter relaxations in response to gastric distension and meal ingestion. Neurogastroenterol Motil 14: 647–655.
95. Sontag S.J. O'Connell S. Khandelwal S. Miller T. Nemchausky B. Schnell T.G. et al (1990) Most asthmatics have gastroesophageal reflux with or without bronchodilator therapy. Gastroenterology 99: 613–620.
96. Spaulding H.S. Jr Mansfield L.E. Stein M.R. Sellner J.C. Gremillion D.E. (1982) Further investigation of the association between gastroesophageal reflux and bronchoconstriction. J Allergy Clin Immunol 69: 516–521.
97. Story G.M. Peier A.M. Reeve A.J. Eid S.R. Mosbacher J. Hricik T.R. et al (2003) ANKTM1, a TRP-like channel expressed in nociceptive neurons, is activated by cold temperatures. Cell 112: 819–829.
98. Trevisani M. Gazzieri D. Benvenuti F. Campi B. Dinh Q.T. Groneberg D.A. et al (2004 a) Ethanol causes inflammation in the airways by a neurogenic and TRPV1-dependent mechanism. J Pharmacol Exp Ther 309: 1167–1173.
99. Trevisani M. Milan A. Gatti R. Zanasi A. Harrison S. Fontana G. et al (2004 b) Antitussive activity of iodo-resiniferatoxin in guinea pigs. Thorax 59: 769–772.
100. Trudgill N.J. Riley S.A. (2001) Transient lower esophageal sphincter relaxations are no more frequent in patients with gastroesophageal reflux disease than in asymptomatic volunteers. Am J Gastroenterol 96: 2569–2574.
101. Tutuian R. Vela M.F. Hill E.G. Mainie I. Agrawal A. Castell D.O. (2008) Characteristics of symptomatic reflux episodes on Acid suppressive therapy. Am J Gastroenterol 103: 1090–1096.
102. Vaezi M.F. (2003) Sensitivity and specificity of reflux–attributed laryngeal lesions: Experimental and clinical evidence. Am J Med 115(Suppl 3A): 97S–104S.
103. Vakil N. van Zanten S.V. Kahrilas P. Dent J. Jones R. (2006) Global Consensus Group. The Montreal definition and classification of the gastroesophageal reflux disease: A global evidence-based consensus. Am J Gastroenterol 101: 1900–1920.
104. Watanabe N. Horie S. Michael G.J. Spina D. Page C.P. Priestley J.V. (2005) Immunohistochemical localization of vanilloid receptor subtype 1 (TRPV1) in the guinea pig respiratory system. Pulm Pharmacol Ther 18: 187–197.
105. Wei H. Koivisto A. Pertovaara A. (2010) Spinal TRPA 1 ion channels contribute to cutaneous neurogenic inflammation in the rat. Neurosci Lett 479: 253–256.
106. Wiener G.J. Tsukashima R. Kelly C. Wolf E. Schmeltzer M. Bankert C. et al (2009) Oropharyngeal pH monitoring for the detection of liquid and aerosolized supraesophageal gastric reflux. J Voice 23: 498–504.
107. Wu D.N. Yamauchi K. Kobayashi H. Tanifuji Y. Kato C. Suzuki K. et al (2002) Effects of esophageal acid perfusion on cough responsiveness in patients with bronchial asthma. Chest 122: 505–509.
108. Zerbib F. Duriez A. Roman S. Capdepont M. Mion F. (2008) Determinants of gastro-oesophageal reflux perception in patients with persistent symptoms despite proton pump inhibitors. Gut 57: 156–160.